Live4Life and NYU

The Live4Life Foundation has made a real difference at NYU Langone Medical Center by continuing to support the fellowship in melanoma translational research. Investments in melanoma fellowships are investments in the young people who will define the research agenda of the future. Not only does the fellowship encourage young talented doctors to pursue a career in research but it also enables ground-breaking research and critical strides in improving the prediction, prevention, treatment and compassionate care for melanoma patients. 

 In the words of Dr. David Polsky, MD, PhD: “I’d like to express my sincere gratitude to Live4Life for your generous philanthropic support these past few years. Your funding of the Translational Research Fellowship has been critical in two important ways: first, in advancing the work of early melanoma detection and identification of risk factors which will benefit generations to come, and, second, in launching the career of a truly gifted researcher and physician, Dr. Lauren Smith.” Live4Life is making an important contribution at NYU Langone Medical Center through the Live4Life Melanoma Translational Research Fellowship and enabling : Bold thinking and translational “bench-to-bedside” research that has the potential to make the greatest gains against melanoma. The goal of the research is to help physicians determine which patients are at highest risk for melanoma so that aggressive interventions may be made at the earliest possible point in time. Dedicated time for future physician-scientists to train in research under the mentorship of an experienced, nationally renowned physician-scientist. The opportunity to pursue research education instills the confidence to pursue a research career and prepares tomorrow’s leaders to surpass our own greatest efforts.

The Live4Life Melanoma Translational Research Fellowship has been a tremendous success and enabled NYU Langone’s Dr. Polsky to hire an extraordinarily-talented young fellow. To date, the fellow has made major contributions to the field of melanoma research, contributing to numerous research papers, including a number as leading author, and delivering several excellent oral presentations at international meetings.

The overall goal of NYU Langone Medical Center’s melanoma research program is to develop clinical tools and laboratory-based tests that can be used by health care providers to identify patients at increased risk for melanoma and to raise awareness among the public regarding melanoma risk factors.

The research continues to focus on: Study of patients with multiple primary melanomas to discover new genes that may predispose patients with one melanoma to develop a second melanoma.

The development of a new model for categorizing patients with atypical moles. The aim of this model is to significantly improve the personalization of melanoma surveillance with the goals of: 1) improving early detection of melanoma; and 2) decreasing unnecessary biopsies of benign lesions. Study of patients belonging to families in which multiple individuals have been diagnosed with melanoma.

In collaboration with NYU molecular geneticist Dr. Tomas Kirchhoff, we are using the most advanced laboratory techniques to discover new genes that may contribute to the development of melanoma.



Live4Life and friends

Leave A Comment